JMN Financial’s Dr. Reddy's Laboratories RDY Stock Holding History

JMN Financial’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15,510	Closed	-$218K	–	230
2025 Q4	$218K	Buy	+15,510	New	+$218K	0.22%	166

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JMN Financial's RDY Position: Q1 2026 in Review

JMN Financial sold out of Dr. Reddy's Laboratories (RDY) in Q1 2026, closing a stake of 15,510 shares — an estimated $218K sold.

JMN Financial first reported a position in RDY in Q4 2025 and held it in 1 quarter. The position peaked at $218K in Q4 2025. 249 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

JMN Financial reported no remaining Dr. Reddy's Laboratories position as of Q1 2026 after selling out during the quarter.
JMN Financial sold 15,510 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $218K.
JMN Financial first reported a position in Dr. Reddy's Laboratories in Q4 2025 and held it in 1 quarter.
JMN Financial's Dr. Reddy's Laboratories position peaked at $218K in Q4 2025.
249 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on JMN Financial's 13F filing for Q1 2026, filed 15 May 2026.